77 related articles for article (PubMed ID: 2872298)
1. Pulmonary absorption of carboxyfluorescein in the rat.
Woolfrey SG; Taylor G; Kellaway IW; Smith A
J Pharm Pharmacol; 1986 Apr; 38(4):304-6. PubMed ID: 2872298
[TBL] [Abstract][Full Text] [Related]
2. Enhancing effect of absorption promoters on percutaneous absorption of a model dye (6-carboxyfluorescein) as poorly absorbable drugs. I. Comparison of plasma levels after addition of various absorption promoters in rat.
Ohshima T; Yoshikawa H; Takada K; Muranishi S
J Pharmacobiodyn; 1984 Sep; 7(9):648-55. PubMed ID: 6527209
[TBL] [Abstract][Full Text] [Related]
3. Enhancing effect of absorption promoters on percutaneous absorption of a model dye (6-carboxyfluorescein) as poorly absorbable drugs. II. Study on the absorption promoting effect of azone.
Ohshima T; Yoshikawa H; Takada K; Muranishi S
J Pharmacobiodyn; 1985 Nov; 8(11):900-5. PubMed ID: 4093845
[TBL] [Abstract][Full Text] [Related]
4. Effect of liposome encapsulation of a fluorescent dye on its uptake by the lymphatics of the rat.
Parker RJ; Sieber SM; Weinstein JN
Pharmacology; 1981; 23(3):128-36. PubMed ID: 7280007
[TBL] [Abstract][Full Text] [Related]
5. Solute disposition in the rat lung in vivo and in vitro: determining regional absorption kinetics in the presence of mucociliary escalator.
Sakagami M; Byron PR; Venitz J; Rypacek F
J Pharm Sci; 2002 Feb; 91(2):594-604. PubMed ID: 11835216
[TBL] [Abstract][Full Text] [Related]
6. Tobramycin disposition in the rat lung following airway administration.
Li M; Byron PR
J Pharmacol Exp Ther; 2013 Nov; 347(2):318-24. PubMed ID: 24008335
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model.
Beck-Broichsitter M; Gauss J; Packhaeuser CB; Lahnstein K; Schmehl T; Seeger W; Kissel T; Gessler T
Int J Pharm; 2009 Feb; 367(1-2):169-78. PubMed ID: 18848609
[TBL] [Abstract][Full Text] [Related]
8. Control of pulmonary absorption of water-soluble compounds by various viscous vehicles.
Yamamoto A; Yamada K; Muramatsu H; Nishinaka A; Okumura S; Okada N; Fujita T; Muranishi S
Int J Pharm; 2004 Sep; 282(1-2):141-9. PubMed ID: 15336389
[TBL] [Abstract][Full Text] [Related]
9. Drug absorption from inhalation aerosols administered by positive-pressure ventilation. II: Effect of disodium fluorescein aerosol particle size on fluorescein absorption kinetics in the beagle dog respiratory tract.
Clark AR; Byron PR
J Pharm Sci; 1985 Sep; 74(9):939-42. PubMed ID: 3906084
[TBL] [Abstract][Full Text] [Related]
10. Improvement of pulmonary absorption of insulin and other water-soluble compounds by polyamines in rats.
He L; Gao Y; Lin Y; Katsumi H; Fujita T; Yamamoto A
J Control Release; 2007 Sep; 122(1):94-101. PubMed ID: 17651854
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent clearance kinetics of intratracheally administered titanium dioxide nanoparticles in rat lung.
Shinohara N; Oshima Y; Kobayashi T; Imatanaka N; Nakai M; Ichinose T; Sasaki T; Zhang G; Fukui H; Gamo M
Toxicology; 2014 Nov; 325():1-11. PubMed ID: 25128818
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics of pulmonary-delivered insulin: a comparison of intratracheal and aerosol administration to the rabbit.
Colthorpe P; Farr SJ; Taylor G; Smith IJ; Wyatt D
Pharm Res; 1992 Jun; 9(6):764-8. PubMed ID: 1409359
[TBL] [Abstract][Full Text] [Related]
13. Enhancing effect of absorption promoters on percutaneous absorption of a model dye (6-carboxyfluorescein) as a poorly absorbable drug. III. Histological study after addition of various absorption promoters in rats.
Ohshima T; Yoshikawa H; Takada K; Muranishi S
J Pharmacobiodyn; 1986 Mar; 9(3):223-8. PubMed ID: 2425072
[TBL] [Abstract][Full Text] [Related]
14. Physiologically based pharmacokinetic modeling of cyclotrimethylenetrinitramine in male rats.
Krishnan K; Crouse LC; Bazar MA; Major MA; Reddy G
J Appl Toxicol; 2009 Oct; 29(7):629-37. PubMed ID: 19629953
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary absorption studies utilizing in situ rat lung model: designing dosage regimen for bronchial delivery of new drug entities.
Chowhan ZT; Amaro AA
J Pharm Sci; 1976 Nov; 65(11):1669-72. PubMed ID: 11336
[TBL] [Abstract][Full Text] [Related]
16. Correlation of drug release with pulmonary drug absorption profiles for nebulizable liposomal formulations.
Beck-Broichsitter M; Rieger M; Reul R; Gessler T; Seeger W; Schmehl T
Eur J Pharm Biopharm; 2013 May; 84(1):106-14. PubMed ID: 23262166
[TBL] [Abstract][Full Text] [Related]
17. Improvement of pulmonary absorption of poorly absorbable macromolecules by hydroxypropyl-β-cyclodextrin grafted polyethylenimine (HP-β-CD-PEI) in rats.
Zhang H; Huang X; Sun Y; Lu G; Wang K; Wang Z; Xing J; Gao Y
Int J Pharm; 2015 Jul; 489(1-2):294-303. PubMed ID: 25959121
[TBL] [Abstract][Full Text] [Related]
18. Absorption kinetics of cyclosporin in the rat.
Hedayati S; Bernareggi A; Rowland M
J Pharm Pharmacol; 1992 Feb; 44(2):122-4. PubMed ID: 1352812
[TBL] [Abstract][Full Text] [Related]
19. Interpretation of absorption rate data for inhaled fluticasone propionate obtained in compartmental pharmacokinetic modeling.
Krishnaswami S; Hochhaus G; Möllmann H; Barth J; Derendorf H
Int J Clin Pharmacol Ther; 2005 Mar; 43(3):117-22. PubMed ID: 15792395
[TBL] [Abstract][Full Text] [Related]
20. The effect of Miglycol 812 oil on the oral absorption of propranolol in the rat.
Woolfrey SG; Palin KJ; Davis SS
J Pharm Pharmacol; 1989 Aug; 41(8):579-81. PubMed ID: 2571709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
